Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

cash money
Biotech

OrbiMed’s largest-ever Asian fund contributes to $3B war chest

OrbiMed has raised $3 billion to place a fresh round of bets on biotechs and life sciences companies in the U.S., Europe and Asia.
Nick Paul Taylor Oct 15, 2026 9:18am
vials vaccine research vaccines factory manufacturing

Osivax focuses on combo strategy for flu shot after ph. 2 fail

Oct 15, 2026 8:07am
iRegene Therapeuticss NouvSight001 Cleared for Clinical Trials in the US and China for Retinitis Pigmentosa

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics
AZ

AstraZeneca, insitro ink $1.5B AI-enabled target discovery deal

Oct 15, 2026 6:00am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
A ballpoint pen rests on top of a stack of documents ready for signing

Rebranded Galapagos finally finds buyer for cell therapies

Oct 15, 2026 4:09am